Alvotech Stock Buy Hold or Sell Recommendation
| ALVO Stock | USD 12.44 0.02 0.16% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Alvotech is 'Strong Sell'. The recommendation algorithm takes into account all of Alvotech's available fundamental, technical, and predictive indicators you will find on this site.
Check out Alvotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide. In addition, we conduct extensive research on individual companies such as Alvotech and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards Alvotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
Alvotech |
Execute Alvotech Buy or Sell Advice
The Alvotech recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Alvotech. Macroaxis does not own or have any residual interests in Alvotech or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Alvotech's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Insignificant | Details | |
Volatility | Not too volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Very High | Details | |
Economic Sensitivity | Moves indifferently to market moves | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Alvotech Trading Alerts and Improvement Suggestions
| Alvotech has a very high chance of going through financial distress in the upcoming years | |
| Alvotech currently holds 1.08 B in liabilities. Alvotech has a current ratio of 0.84, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Alvotech's use of debt, we should always consider it together with its cash and equity. | |
| The entity reported the previous year's revenue of 91.43 M. Net Loss for the year was (551.73 M) with profit before overhead, payroll, taxes, and interest of 20.92 M. | |
| Alvotech currently holds about 128.44 M in cash with (312.19 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52. | |
| Roughly 64.0% of the company shares are held by company insiders | |
| Latest headline from gurufocus.com: Alvotech Q3 2024 Earnings Call Highlights Record Revenue Growth and Strategic Advancements |
Alvotech Returns Distribution Density
The distribution of Alvotech's historical returns is an attempt to chart the uncertainty of Alvotech's future price movements. The chart of the probability distribution of Alvotech daily returns describes the distribution of returns around its average expected value. We use Alvotech price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Alvotech returns is essential to provide solid investment advice for Alvotech.
| Mean Return | -0.01 | Value At Risk | -2.83 | Potential Upside | 3.15 | Standard Deviation | 1.69 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Alvotech historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Alvotech Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Alvotech or Biotechnology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Alvotech's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Alvotech stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.02 | |
β | Beta against Dow Jones | -0.09 | |
σ | Overall volatility | 1.63 | |
Ir | Information ratio | -0.06 |
Alvotech Volatility Alert
Alvotech exhibits very low volatility with skewness of 0.36 and kurtosis of 0.84. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Alvotech's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Alvotech's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Alvotech Fundamentals Vs Peers
Comparing Alvotech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Alvotech's direct or indirect competition across all of the common fundamentals between Alvotech and the related equities. This way, we can detect undervalued stocks with similar characteristics as Alvotech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Alvotech's fundamental indicators could also be used in its relative valuation, which is a method of valuing Alvotech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Alvotech to competition |
| Fundamentals | Alvotech | Peer Average |
| Return On Asset | -0.0761 | -0.14 |
| Profit Margin | (2.00) % | (1.27) % |
| Operating Margin | 0.46 % | (5.51) % |
| Current Valuation | 4.81 B | 16.62 B |
| Shares Outstanding | 301.94 M | 571.82 M |
| Shares Owned By Insiders | 64.01 % | 10.09 % |
| Shares Owned By Institutions | 6.03 % | 39.21 % |
| Number Of Shares Shorted | 79.01 K | 4.71 M |
| Price To Sales | 12.15 X | 11.42 X |
| Revenue | 91.43 M | 9.43 B |
| Gross Profit | 20.92 M | 27.38 B |
| EBITDA | (484.86 M) | 3.9 B |
| Net Income | (551.73 M) | 570.98 M |
| Cash And Equivalents | 128.44 M | 2.7 B |
| Cash Per Share | 0.52 X | 5.01 X |
| Total Debt | 1.08 B | 5.32 B |
| Current Ratio | 0.86 X | 2.16 X |
| Book Value Per Share | (3.50) X | 1.93 K |
| Cash Flow From Operations | (312.19 M) | 971.22 M |
| Short Ratio | 0.58 X | 4.00 X |
| Earnings Per Share | (1.85) X | 3.12 X |
| Target Price | 17.4 | |
| Number Of Employees | 999 | 18.84 K |
| Beta | -0.097 | -0.15 |
| Market Capitalization | 3.75 B | 19.03 B |
| Total Asset | 950.09 M | 29.47 B |
| Retained Earnings | (2.21 B) | 9.33 B |
| Working Capital | (66.11 M) | 1.48 B |
| Net Asset | 950.09 M |
Alvotech Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Alvotech . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Alvotech Buy or Sell Advice
When is the right time to buy or sell Alvotech? Buying financial instruments such as Alvotech Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Alvotech in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Giant Impact Thematic Idea Now
Giant Impact
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Alvotech Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alvotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.70) | Earnings Share (1.85) | Revenue Per Share 1.283 | Quarterly Revenue Growth 43.997 | Return On Assets (0.08) |
The market value of Alvotech is measured differently than its book value, which is the value of Alvotech that is recorded on the company's balance sheet. Investors also form their own opinion of Alvotech's value that differs from its market value or its book value, called intrinsic value, which is Alvotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alvotech's market value can be influenced by many factors that don't directly affect Alvotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alvotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alvotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alvotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.